BenzingaBenzinga

Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'

On CNBC's “Mad Money Lightning Round,” Jim Cramer  recommended selling Petróleo Brasileiro S.A. – Petrobras PBR. “I like PBR the beer more than I like PBR the oil company,” he added.

Cramer recommended buying Enterprise Products Partners L.P. EPD.

On April 4, Wells Fargo analyst Michael Blum maintains Enterprise Products Partners with an Overweight rating and raised the price target from $32 to $33, while Scotiabank analyst Tristan Richardson maintained the stock with a Sector Outperform and boosted the price target from $31 to $32.

Cheniere Energy, Inc. LNG is “terrific,” Cramer said.

The “Mad Money” host recommended buying Recursion Pharmaceuticals, Inc. RXRX. “I think you have a real winner,” he noted.

On April 16, Recursion named Najat Khan, PhD, as chief R&D officer and chief commercial officer.

Cramer said Casey’s General Stores, Inc. CASY is a “winner” and recommended buying the stock.

On April 16, Evercore ISI Group analyst Michael Montani maintained Casey’s General with an Outperform and lowered the price target from $350 to $345.

Broadcom Inc. AVGO is a buy, Cramer said.

On Monday, critics of Broadcom dismissed the U.S. chipmaker's revisions to its cloud licensing practices, arguing that the changes fail to resolve their concerns over alleged price increases, unfair software licensing terms, and product bundling.

Price Action:

  • Petroleo Brasileiro shares rose 0.1% to settle at $16.96 on Tuesday.
  • Broadcom shares gained 2% to settle at $1,249.19.
  • Casey's General Stores shares fell 0.1% to close at $313.32 on Tuesday.
  • Enterprise Products Partners shares fell 0.3% to close at $28.91.
  • Recursion Pharmaceuticals shares rose 1.3% to settle at $7.70 on Tuesday.
  • Cheniere Energy shares fell 1% to close at $158.90 on Tuesday.

Read Next: Meta Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

Photo: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Login or create a forever free account to read this news